Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
D000814:Aniline Compounds / Q000032:analysis; D000818:Animals; D002994:Clofibrate / Q000494:pharmacology*; D004247:DNA / Q000032:analysis; D004347:Drug Interactions; D004721:Endoplasmic Reticulum / Q000187:drug effects; D006529:Hepatomegaly / Q000139:chemically induced* / Q000473:pathology; D006591:Hexobarbital / Q000032:analysis / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008099:Liver / Q000032:analysis; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000032:analysis / Q000378:metabolism; D009281:Naphthalenes / Q000494:pharmacology*; D009929:Organ Size; D010636:Phenols / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology*; D012313:RNA / Q000032:analysis; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000814:Aniline Compounds; D000960:Hypolipidemic Agents; D009281:Naphthalenes; D010636:Phenols; D011422:Propionates; D012313:RNA; D004247:DNA; D006591:Hexobarbital; D002994:Clofibrate